Complicating the issue of Tregs in cancer progression, a recent meta-analysis revealed that increased frequencies of Foxp3+ Tregs correlated with decreased overall survival in several cancers, but correlated with a better prognosis in head and neck, esophageal, and colorectal cancers (74). The gene discussed is FOXP3; the disease is cancer.